Multi-axis Assessment of Injured Workers
Launched by DAVE WALTON · Aug 25, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to improve how injured workers in Ontario with musculoskeletal injuries, like back pain or strains, are treated so they can return to work more quickly. The goal is to create a system that helps identify the right health services for these workers within the first eight weeks of their injury claim. By doing this, the researchers hope to increase the number of workers who can get back to work sooner and reduce the time they spend away from their jobs due to injury.
If you’re over 18 years old and have a workplace injury involving musculoskeletal issues, you may be eligible to participate. Participants will be asked to share information about their condition when they start the program and again a few weeks later to track their recovery. The study aims to include about 300 to 350 workers over two years. This is an important opportunity to help shape better care for those dealing with work-related injuries, and all participants will receive support as they move through their rehabilitation.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Eligible participants are those aged ≥18 years, able to read 6th grade English, presenting to a program of care for rehabilitation of a workplace injury with a primary musculoskeletal or Low Back Pain component.
- • Exclusion Criteria: Participants with significant cognitive impairment or learning disability (self-reported) that interfere with following multi-step instructions will be excluded from this study. The exclusive focus on those entering program of care-based rehab will naturally exclude workers with catastrophic injuries (e.g., loss of limb, multiple fractures, burns) or those for whom a mental health disorder (e.g., PTSD, depression) is the primary diagnosis, thereby homogenizing the types of injuries included.
About Dave Walton
Dave Walton is a dedicated clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a strong background in clinical development and regulatory affairs, he oversees a diverse portfolio of trials aimed at evaluating innovative therapies across various therapeutic areas. Walton's approach emphasizes collaboration with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of clinical studies. His leadership is characterized by a focus on ethical standards, patient safety, and the acceleration of breakthroughs in healthcare, making him a respected figure in the clinical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multiple Locations, Ontario, Canada
Patients applied
Trial Officials
David Walton, PhD
Principal Investigator
CANSpine Lab, School of Physical Therapy, Western University, Canada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported